Device Trial Radar · NCT00873106
Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography
Last checked: Nov 19, 2026Latest source record: Sep 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Feb 2009
Primary completion
Mar 2010
Study completion Mar 2010
Sponsor
- Lead sponsor
- Glostrup University Hospital, CopenhagenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 1, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the present study is to determine if the retinal thickness estimates of the Stratus OCT, the 3D OCT-1000, and the CirrusHD OCT are comparable in diabetic and in healthy individuals (OCT=Optical Coherence Tomography).
Conditions
- Healthy
- Diabetic Maculopathy
Interventions
Optical coherence tomographyDevice
Stratus OCT: fast radial lines 3D OCT-1000: radial 2048 and 3D OCT Cirrus HD OCT: 3D OCT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retinal thickness and retinal volume from each OCT scanTime frame: within 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57
Glostrup Municipality, Copenhagen, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.